Safety and Efficacy of G17DT Immunogen Combined With Gemcitabine vs. Gemcitabine in the Treatment of Advanced Pancreatic Carcinoma
Clinical trial NCT00044031 · COMPLETED
Trial details
- NCT number
- NCT00044031
- Sponsor
- Cancer Advances Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2001-02-01
- Primary completion
- 2004-04-01
- Enrollment
- 394
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.